Nonsteroidal antiinflammatory drug use among women and the risk of birth defects

American Journal of Obstetrics and Gynecology

Volumn 206, Issue 3, 2012, Pages 228.e1-228.e8

  Hernandez, Rohini K ^a   Werler, Martha M ^b   Romitti, Paul ^c   Sun, Lixian ^c   Anderka, Marlene ^a  

^a MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

birth defect; medication in pregnancy; National Birth Defects Prevention Study; nonsteroidal antiinflammatory drug

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AMNION BAND SYNDROME; ANOPHTHALMIA; BIRTH DEFECT; CLEFT LIP PALATE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INFANT; LIMB DEFECT; MAJOR CLINICAL STUDY; MALE; MATERNAL SMOKING; MICROPHTHALMIA; NEURAL TUBE DEFECT; POPULATION BASED CASE CONTROL STUDY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PULMONARY VALVE STENOSIS; RISK FACTOR;

EID: 84857788612     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.11.019     Document Type: Conference Paper

References (13)

1. G.K. McEvoy AHFS Drug Information 2010 2010 American Society of Health-System Pharmacists Bethesda, MD
2. M.M. Werler, A.A. Mitchell, S. Hernandez-Diaz, M.A. Honein National Birth Defects Prevention Study Use of over-the-counter medications during pregnancy Am J Obstet Gynecol 193 2005 771 777
3. E. Kozer, S. Nikfar, A. Costei, R. Boskovic, I. Nulman, G. Koren Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis Am J Obstet Gynecol 187 2002 1623 1630
4. P.W. Yoon, S.A. Rasmussen, M.C. Lynberg The National Birth Defects Prevention Study Public Health Rep 116 suppl 2001 32 40
5. S.A. Rasmussen, R.S. Olney, L.B. Holmes Guidelines for case classification for the National Birth Defects Prevention Study Birth Defects Res A Clin Mol Teratol 67 2003 193 201
6. M.E. Cogswell, R.H. Bitsko, M. Anderka Control selection and participation in an ongoing, population-based, case-control study of birth defects: the National Birth Defects Prevention Study Am J Epidemiol 170 2009 975 985
7. L. Botto, A.E. Lin, T. Riehle-Colarusso, S. Malik, A. Correa National Birth Defects Prevention Study Seeking causes: classifying and evaluating congenital heart defects in etiologic studies Birth Defects Res A Clin Mol Teratol 79 2007 714 727
8. M.L. Feldkamp, R.E. Meyer, S. Krikov, L.D. Botto Acetaminophen use in pregnancy and risk of birth defects: findings from the National Birth Defects Prevention Study Obstet Gynecol 115 2010 109 115
9. M.A. Cleves, V.H. Savell, S. Raj Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects Birth Defects Res A Clin Mol Teratol 70 2004 107 113
10. M.M. Werler, A.A. Mitchell, C.A. Moore, M.A. Honein National Birth Defects Prevention Study Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? Am J Med Genet A 149A 2009 1399 1406
11. M.M. Werler, J.L.F. Bosco, S.K. Shapira National Birth Defects Prevention Study Maternal vasoactive exposures, amniotic bands, and terminal transverse limb defects Birth Defects Res A Clin Mol Teratol 85 2009 52 57
12. A. Ericson, B. Kallen Nonsteroidal anti-inflammatory drugs in early pregnancy Reprod Toxicol 15 2001 371 375
13. M.M. Werler, J.E. Sheehan, C. Hayes, A.A. Mitchell, J.B. Mulliken Vasoactive exposures, vascular events, and hemifacial microsomia Birth Defects Res A Clin Mol Teratol 70 2004 389 395